IDEXX實驗室 IDXX 深 滬
已收盤 05-08 16:00:00 美东时间
560.11
-12.090
-2.11%
華盛通- 最 高572.20
- 今 開572.20
- 成交量 47.66万股
- 最 低 555.185
- 昨 收 572.20
- 總市值 441.83亿
- 52周最高 769.98
- 市盈率 靜 42.84
- 換手率 0.60%
- 52周最低 496.61
- 委 比 87.50%
- 總股本 7888.30万
- 歷史最高 769.98
- 量 比 0.68
- 振 幅 2.97%
- 歷史最低 31.915
- 每 手 1
- 風險率 67.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Most healthcare companies report higher Y/Y EPS in strong earnings week
Healthcare companies delivered strong earnings this week, with 18 out of 20 companies beating EPS estimates and 15 topping revenue expectations, as resilient demand across pharmaceuticals, healthcare ...
05-09 23:30
Zoetis cuts 2026 outlook as U.S. sales fall in Q1
Shares of Zoetis (ZTS) fell ~13% in the premarket on Thursday after the veterinary product maker lowered its full-year outlook, citing a challenging first quarter marked by a decline in its U.S. reven...
05-07 20:24
财报速睇 | IDEXX实验室 2026财年Q1营收11.41亿美元，同比增长14.3%；归母净利润2.78亿美元，同比增长14.7%
华盛资讯5月6日讯，IDEXX实验室公布2026财年Q1业绩，公司Q1营收11.41亿美元，同比增长14.3%，归母净利润2.78亿美元，同比增长14.7%。
05-06 05:53
Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency
Idexx Laboratories shares edge higher as revenue tops estimates but earnings per share misses; guidance raised.
05-05 22:20
Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call
On Tuesday, IDEXX Laboratories (NASDAQ:IDXX) discussed first-quarter financial ...
05-05 21:48
财报速睇 | IDEXX实验室 2026财年Q1营收11.41亿美元，同比增长14.3%；归母净利润2.78亿美元，同比增长14.4%
华盛资讯5月5日讯，IDEXX实验室公布2026财年Q1业绩，公司Q1营收11.41亿美元，同比增长14.3%，归母净利润2.78亿美元，同比增长14.4%。
05-05 21:31
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
IDEXX Laboratories Q1 Adj. EPS $3.30 Misses $3.40 Estimate, Sales $1.141B Beat $1.109B Estimate
IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.30 per share which missed the analyst consensus estimate of $3.40 by 2.94 percent. This is a 14.98 percent increase over earnings of $2.87 per share from
05-05 18:31
美股大行评级 | 达美乐比萨惨遭10家大行下调目标价；铿腾电子、艾克尔科技、Relay 、辛普森配件制造、TFI International等获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Intellia Therapeutics"买入"评级，目标价从48美元升至58美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从7美元升至8美元
04-29 10:28
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $640
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $730 to $640.
04-28 22:22
